Literature DB >> 15477340

Twenty-five years of treating advanced NSCLC: what have we achieved?

G Giaccone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15477340     DOI： 10.1093/annonc/mdh908

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells.

Authors:  Zeynep Birsu Cincin; Miray Unlu; Bayram Kiran; Elif Sinem Bireller; Yusuf Baran; Bedia Cakmakoglu
Journal:  Cell Oncol (Dordr)       Date:  2015-04-10       Impact factor: 6.730

Review 2.  Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer.

Authors:  Samiha Mateen; Komal Raina; Rajesh Agarwal
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

3.  Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial.

Authors:  G P Stathopoulos; D Antoniou; J Dimitroulis; P Michalopoulou; A Bastas; K Marosis; J Stathopoulos; A Provata; P Yiamboudakis; D Veldekis; N Lolis; N Georgatou; M Toubis; Ch Pappas; G Tsoukalas
Journal:  Ann Oncol       Date:  2010-05-03       Impact factor: 32.976
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.